3.72
-0.02 (-0.40%)
| Penutupan Terdahulu | 3.73 |
| Buka | 3.73 |
| Jumlah Dagangan | 327,659 |
| Purata Dagangan (3B) | 686,889 |
| Modal Pasaran | 240,350,832 |
| Harga / Buku (P/B) | 1.27 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 11 Nov 2026 |
| EPS Cair (TTM) | -1.97 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 9.76% |
| Nisbah Semasa (MRQ) | 7.48 |
| Aliran Tunai Operasi (OCF TTM) | -53.59 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -32.40 M |
| Pulangan Atas Aset (ROA TTM) | -57.90% |
| Pulangan Atas Ekuiti (ROE TTM) | -102.47% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Immuneering Corporation | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | NA |
| AI Insight | NA |
| Purata | 0.50 |
|
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 24.12% |
| % Dimiliki oleh Institusi | 12.55% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
AI Analisis Teknikal
Buka tab Teknikal untuk menjana analisis terkini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |